ChemoCentryx

CCXI

CCXI
ChemoCentryx Stock Quote
$40.74 -$1.78 -4.2%
BATS BZX Real Time Price as of January 23, 2020, 4:30 p.m. EST View Interactive CCXI Charts

Chemocentryx Inc. is a biopharmaceutical company focused on discovering developing and commercializing orally-administered therapeutics to treat autoimmune diseases inflammatory disorders and cancer.

News & Analysis: ChemoCentryx

All

Market Moves

Earnings





Is This Small-Cap Biotech a Buy Before 2020?

Stocks of drug developers, particularly small ones, can skyrocket or crater based on late-stage clinical trials. Before year-end, ChemoCentryx may do one or the other.







Interactive Chart